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Abstract 
Glutathione deficiency produced by giving buthionine sulfoximine (an inhibitor of y-glutamylcysteine synthetase) toanimals, leads to 
biphasic decline in cellular glutathione l vels associated with sequestration f glutathione in mitochondria. Liver mitochondria l ck the 
enzymes needed for glutathione synthesis. Mitochondrial glutathione arises from the cytosol. Rat liver mitochondria have a muiticompo- 
nent system (with KmS of approx. 60 /xM and 5.4 mM) that underlies their remarkable ability to transport and retain glutathione. 
Mitochondria produce substantial quantities of reactive oxygen species; this is opposed by reactions involving glutathione. Glutathione 
deficiency leads to widespread mitochondrial damage which is lethal in newborn rats and guinea pigs, animals that do not synthesize 
ascorbate. Glutathione sters and ascorbate protect against he lethal and other effects of glutathione deficiency. Ascorbate spares 
glutathione; it increases mitochondrial glutathione in glutathione-deficient animals. Glutathione sters delay onset of scurvy in 
ascorbate-deficient guinea pigs; thus, glutathione spares ascorbate. Glutathione and ascorbate function together in protecting mitochondria 
from oxidative damage. 
Keywords: Glutathione deficiency; Buthionine sulfoxide; Reactive oxygen species; Ascorbate 
1. Introduction 
Our interest in mitochondria developed from studies on 
the effects of glutathione (GSH) deficiency. Glutathione, 
which is not required in the diet of animals, is synthesized 
in almost all animal cells by the consecutive actions of 
y-glutamylcysteine synthetase and glutathione synthetase 
(reactions (1) and (2)). (For reviews of glutathione bio- 
chemistry, see Refs. [1-4].) 
L -- Glutamate + L -- cysteine + ATP 
L -- ~/-- glutamyl -- L -- cysteine + ADP + Pi ( 1 ) 
L -- "y -- Glutamyl - L -- cysteine + glycine + ATP 
glutathione + ADP + Pi (2) 
To elucidate the functions of glutathione, we sought o 
selectively remove this tripeptide from the cells and then 
to determine the consequences of its deletion [5,6]. To 
accomplish this, we administered to animals a transition 
state inhibitor of y-glutamylcysteine synthetase (buthionine 
sulfoximine; BSO). BSO, after phosphorylation by ATP on 
the enzyme, binds tightly to its active site thus inhibiting it 
irreversibly. Cellular levels of glutathione decrease after 
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administration of BSO because xport of glutathione from 
the cells continues in the absence of appreciable glu- 
tathione synthesis. 
Glutathione deficiency produced in guinea pigs and 
newborn rats leads to death within a few days; adult mice 
and rats exhibit morbidity associated with damage to vari- 
ous tissues including lung and certain organs of the gastro- 
intestinal tract [5]. Cellular damage largely involves the 
mitochondria, but other effects are also observed (e.g., 
nuclear changes, type 2 lung cell lamellar body damage). 
Mortality and tissue damage are found after giving the 
animals L-buthionine-SR-sulfoximine, butnot after admin- 
istration of L-buthionine-R-sulfoximine, a diastereomer of
BSO that does not inhibit y-glutamylcysteine synthetase. 
Animals treated with L-buthionine-SR-sulfoximine plus 
glutathione monoethyl ester (a cellular glutathione delivery 
agent [7,8]), exhibit greatly decreased mortality and mor- 
bidity. For example, cataracts produced in newborn rats by 
giving BSO are almost completely prevented in dose-de- 
pendent fashion by administration of glutathione sters [9]. 
Cells normally produce considerable quantities of reac- 
tive oxygen species, and mitochondria re a major source 
of oxidants [10-13]. The cellular damage found after 
administration of BSO is thus of endogenous origin as 
opposed to that produced, for example, by application of 
oxidizing agents. The considerable cellular damage found 
in glutathione deficiency reflects the extensive formation 
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Fig. 1. Effect of BSO treatment on heart (solid symbols) and skeletal 
muscle (open symbols). Mice were injected intraperitoneally with BSO 
and given BSO in the drinking water; treatment was stopped after 500 h. 
See [15] for other details. Insert, logarithmic plot of the data (from [15]). 
of reactive oxygen intermediates that occurs normally and 
which is normally opposed by reactions involving glu- 
tathione, e.g., that catalyzed by glutathione peroxidase. 
There are other mechanisms for destruction of reactive 
oxygen intermediates, e.g., of hydrogen peroxide by cata- 
lase, and as discussed below, ascorbate also has a role in 
this process. 
1.1. On the origin of mitochondrial glutathione 
The levels of glutathione in the liver and kidney of mice 
given BSO decrease within 30-60 rain to values that are 
15-20% of those of untreated controls. Further decrease of 
the tissue glutathione level occurs only very slowly even 
when more BSO is given; see, for example, Fig. 1 in Ref. 
[14], and Fig. 1 (present paper) [15]. The observed biphasic 
disappearance of glutathione after giving BSO suggested 
that a separate pool of glutathione is sequestered in certain 
cell types or within cell organelles. The finding that mito- 
chondrial glutathione decreases much more slowly than 
total tissue glutathione after giving BSO [16] suggested 
that there is a separate mitochondrial pool of glutathione. 
We found that administered BSO does not appreciably 
penetrate into rat liver mitochondria []7], so that it was 
possible that mitochondrial glutathione synthesis occurs 
and that it is protected from BSO inhibition. In other 
studies we found that the rates of the incorporation of 
administered [35S]cyst(e)ine into liver cytosolic and mito- 
chondrial glutathione are closely similar. In addition, when 
mice treated with [35S]cyst(e)ine were then given L-2- 
oxothiazolidine-4-carboxylate, n intracellular cysteine 
precursor [16], the rates at which the specific radioactivi- 
ties of cytosolic and mitochondrial glutathione declined 
were about the same. 
To further explore this problem, we sought o determine 
whether liver mitochondria have the capacity to synthesize 
glutathione. We found no mitochondrial y-glutamylcy- 
steine synthetase under conditions in which an activity of 
0.1 nmol/h per mg of protein could have been detected. 
On this basis, the y-glutamylcysteine synthetase activity is 
< 0.1% of the cytosolic activity of this enzyme. A very 
low level of glutathione synthetase and of other y-glutamyl 
cycle enzymes was also found (Table 1) [16]. The very low 
levels of several enzyme activities found in mitochondria 
may probably be ascribed to a small contamination with 
cytosol. 
The studies with BSO indicate that there is a very slow 
net flow of glutathione from mitochondria to the cytosol. 
However, the studies with labelled cyst(e)ine cited above 
show that there is a fairly rapid exchange of glutathione 
between the cytosol and the mitochondria. The findings 
indicate that mitochondrial glutathione in liver does not 
arise by intramitochondrial synthesis, but rather from the 
cytosol, by a transport process characterized by slow net 
transport and more rapid exchange transport [16] (Fig. 2). 
That the net effiux of glutathione from mitochondria is
very small suggests that this transport mechanism func- 
tions to conserve mitochondrial glutathione when there is 
cytosolic glutathione depletion. Reversible conversion of 
glutathione to glutathione disulfide occurs in the cytosol 
and in the mitochondria, but the synthesis of glutathione 
seems to occur only in the cytosol. Glutathione, rather than 
Table 1 
Activity of 7-glutamyl cycle enzymes in cytoplasmic and mitochondrial fractions of rat liver 
Enzyme Enzyme activity, nmol/h per mg of protein 
Cytoplasm Mitochondria 
y-Glutamylcysteine synthetase 83 _4- 2 0 
GSH synthetase 215 _+ 16 0.7 + 0.2 
y-Glutamyltranspeptidase 5.6 0 
7-Glutarnylcyclotransferase 4470 + 170 7.6 4- 0.4 
5-Oxoprolinase 22.7 + 1.3 0 
See [16] for experimental details. 
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Fig. 2. Glutathione is transported from the cytosol into mitochondria 
(from [16]). 
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Fig. 3. Time course of GSH uptake into mitochondrial matrix at high and 
low external GSH concentrations. Curves: 1, 10 mM GSH; 2, 1 mM GSH 
(from [33]). 
glutathione disulfide, is probably the major transport form 
since glutathione is the predominant intracellular form. 
The observed rapid labelling of mitochondrial gtutathione 
after administration of labelled cyst(e)ine is in accord with 
the view that there is an exchange carder in the mitochon- 
drial membrane that is accessible to both mitochondrial 
and cytosolic glutathione. 
The results reviewed above extend earlier findings [18- 
29] on mitochondrial glutathione. Although it has long 
been known that mitochondria contain glutathione, its 
origin was at first unclear [25,26,29]. Studies on isolated 
rat liver mitochondria provided support for the conclusion 
that there are glutathione transporters in mitochondria. 
This was initially indicated by studies in which isolated rat 
liver mitochondria were suspended in solutions containing 
5-10 mM glutathione and in which the total glutathione 
levels were found to increase [30-32]. Studies were later 
done on the kinetics of glutathione transport by isolated 
liver mitochondria n which the rates of glutathione trans- 
port were measured into and out of the mitochondrial 
matrix at low and high external glutathione levels and at 
short time intervals (e.g., 15 s)(Fig. 3)[33]. These studies 
showed that the initial rates of glutathione uptake into the 
mitochondrial matrix reflected the function of a multicom- 
ponent system (Fig. 4). At low external evels of glu- 
tathione (0.05-1 mM), a high affinity component was 
observed, which had an apparent K m value of about 60 
/xM and an apparent Vma x of 0.54 nmol/min per mg of 
protein. This component was saturated at an external glu- 
tathione level of 1-2 mM. At an external evel of glu- 
tathione of 1-8 mM, a low affinity component was ob- 
served which had an apparent K m value of 5.4 mM and 
Vma x of 5.79 nmol/min per mg of protein. Both high and 
low affinity uptake processes were stimulated by ATP and 
ADP, and inhibited by FCCP (carbonyl cyanide p-(trifluo- 
romethoxy)phenyl h drazone). When the external levels of 
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Fig. 4. GSH uptake into the matrix with various external concentrations of GSH. Uptake was determined after 15 s. The data are shown as Eadie-Hofstee 
plots. Inserts A and B: Plots are of the data for the high-affinity (A) and low-affinity (B) components. Error bars indicate + S.E. (n = 3-5) (from [33]). 
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Fig. 5. GSH efflux-exchange from the matrix at various external levels of 
GSH. Curves: 1, 0.15 mM GSH; 1, 2.8 mM GSH. When the experiment 
described in Curve 2 was carried out in the presence of 1 mM ADP (state 
3 respiration), about 45% of the [35S]GSH was found in the matrix after 
120 s. Closed triangle, 4 mM GSH (from [33]). 
glutathione were 8-10 mM or higher, uptake into the 
matrix seemed to occur by diffusion. Under the conditions 
used [33] most (84-88%) of the glutathione taken up (as 
determined with 35S-labelled GSH) was present as free 
glutathione; the remainder was protein-bound. 
Efflux of [35S]glutathione from [35S]glutathione-pre- 
loaded mitochondria was apparently biphasic with an ex- 
ternal glutathione level of 0.15 mM (Fig. 5). The initial 
rates of glutathione fflux from the matrix were substan- 
tially increased when the external level of glutathione was 
increased. When the external concentration of glutathione 
was 8 mM, about 60% of the [35S]glutathione initially 
present in the matrix disappeared from the matrix after 15 
s, Notably, after 120 s, all of the initially effluxed 
[3SS]glutathione was recovered in the matrix. On the as- 
sumption that the preloading procedure labels the matrix 
glutathione homogeneously, the initial efflux and subse- 
quent reuptake of [35S]glutathione suggests that there is a 
rapid efflux of [35S]glutathione from the matrix and that 
the effluxed [35S]glutathione does not equilibrate with the 
unlabelled glutathione of the medium. Such lack of equili- 
bration would be expected if the effluxed [35S]glutathione 
were retained, under these conditions, in the intermem- 
brane space. This apparent efflux and reuptake of glu- 
tathione was found with an external glutathione l vel of 8 
raM, but not with one of 0.15 raM. It appears that with an 
external glutathione l vel of 8 raM, there is rapid flow of 
external glutathione into the intermembranous space; this 
seems to efficiently facilitate reuptake of [35S]glutathione 
into the matrix. The findings thus indicate that there is 
exchange of glutathione between the matrix and the inter- 
membranous pace, which is accelerated by increasing 
external glutathione l vels. 
The finding of a high affinity transporter for glutathione 
seems to explain the remarkable affinity of mitochondria 
for glutathione. Earlier studies in which uptake of glu- 
tathione was examined at external glutathione levels of 
5-10 mM and in which rates were calculated from experi- 
ments carried out over a period of several minutes [30-32] 
are probably reflective of the low affinity transporter. The 
data suggest hat the uptake of glutathione is an active 
energy requiring process, except in situations in which 
there are very high cytosolic levels of glutathione in which 
case the transport is diffusion-controlled. The effiux of 
glutathione from the matrix in the presence of low external 
levels of glutathione is biphasic, the initial part of which 
was not observed when the mitochondria were prepared in 
the absence of EDTA. Unless EDTA is added, a substan- 
tial amount of matrix glutathione is lost during preparation 
[33]. 
That increasing external glutathione levels accelerates 
exchange across the inner mitochondrial membrane in 
vitro is in accord with in vivo findings. Thus, as noted 
above, depletion of tissue glutathione by giving BSO leads 
to marked decrease of cytosolic glutathione without com- 
parable decline of mitochondrial glutathione. Administra- 
tion of glutathione sters to glutathione-depleted animals 
produces substantial increase in the mitochondrial glu- 
tathione level without comparable increase of the cytosolic 
glutathione level [5,15]. These in vivo findings are inter- 
pretable in terms of decreased effiux of matrix glutatbione 
in the presence of low cytosolic glutathione l vels and the 
existence of glutathione transporters in the intermitocbon- 
drial membrane [33]. It is possible that glutathione sters 
are transported into mitochondria and split to glutathione; 
data on this point are still needed. It should be emphasized 
that much more work is needed to extend these observa- 
tions, for example, to learn whether glutathione trans- 
porters are present in mitochondria isolated from other 
tissues and other species. 
1.2. Mitochondrial damage due to glutathione deficiency: 
prevention by glutathione sters and by ascorbate 
As discussed above, mitochondria normally produce 
substantial quantities of reactive oxygen species. Thus, as 
shown by Chance and his colleagues [10,11] a significant 
fraction (perhaps 2-5%) of the oxygen utilized by mito- 
chondria is converted, apparently via superoxide, to hydro- 
gen peroxide. Normally this is efficiently destroyed by the 
action of glutathione peroxidase, but when there is glu- 
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Fig. 6. Mitochondrial damage and GSH levels in tissues of newborn rats 
and adult mice (from [36]). 
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Fig. 7. Representative el ctron micrographs of the epithelial zone of the lens of a control mouse 6 h after birth (A), and an age-matched mouse from a 
mother treated with buthionine sulfoximine (B). In B, there is marked mitochondrial swelling and degeneration a d vacuole formation. (A, bar = 0.4/xm. 
X 17 150; B, bar = 37/zm, X 13500) (from [9]). 
tathione deficiency, reactive oxygen species accumulate 
leading to mitochondrial and other types of cell damage. 
Mitochondrial damage, which was found in a number of 
cell types, was indicated by determinations of citrate syn- 
thase and by electron microscopy. For example, adminis- 
tration of BSO to adult mice led to marked skeletal muscle 
damage characterized by myofiber necrosis and evidence 
of mitochondrial swelling and vacuolization with rupture 
of cristae and mitochondrial membrane disintegration [15]. 
Under these conditions there was a substantial decrease 
(approx. 80%) in the levels of citrate synthase. The levels 
of glutathione in skeletal muscle and in the mitochondria 
isolated from this tissue were significantly decreased in 
adult mice treated with BSO. When the animals were 
treated with BSO together with glutathione monoester the 
levels of mitochondrial glutathione were about the same as 
found in untreated controls and electron microscopy 
showed no evidence of mitochondrial degeneration. 
Effects similar to those found in skeletal muscle were 
also observed in other tissues of adult mice treated with 
BSO, for example, in the lung [34], jejunum, and colon 
[35]. There appears to be a fair correlation between the 
extent of mitochondrial glutathione depletion and mito- 
chondrial and other cell damage (Fig. 6) [36]. Thus, mito- 
chondrial and lamellar body damage in lung type 2 cells 
were found in association with mitochondrial glutathione 
levels that were about 21% of the controls. Jejunal mu- 
cosal damage was found when the mitochondrial glu- 
tathione levels were about 13% of the controls. In each 
instance treatment with glutathione ster prevented mito- 
chondrial damage. (As discussed below, treatment with 
ascorbate also prevented such damage.) 
When newborn mice or rats are rendered glutathione 
deficient by treatment with BSO soon after birth, they 
develop cataracts in association with markedly decreased 
levels of glutathione in the lens; electron microscopy of 
SALINE BSO BSO+6SII BS GSH-ESTER 
Fig. 8. Mitochondrial damage in cerebral cortex of newborn rats after BSO administration. The rats were given saline (a), BSO (b), BSO + GSH (c), or 
BSO + GSH ester (d) as stated in [38] from 48 h to 11 days of age. In b and c there is marked mitochondrial swelling and by arrows. ( X 6000; bar in lower 
left-hand comer = 0.37 txm) (from [38]). 
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the epithelial zone of the treated animals revealed marked 
mitochondrial swelling and degeneration with vacuole for- 
mation (Fig. 7) [9]. In these studies, the newborn animals 
were given relatively small doses of BSO soon after birth; 
cataracts were evident when the animals open their eyes 
12-16 days later. No cataracts were found after treating 
mice older than 14 days. When pregnant mice were given 
BSO on days 15-19 of gestation the newborns developed 
cataracts, but no cataracts were found in the treated moth- 
ers. The development of cataracts was associated with 
markedly decreased levels of glutathione in the lens and in 
isolated lens mitochondria. Cataract formation was de- 
creased markedly or prevented entirely by simultaneous 
administration of glutathione sters [9] (or of ascorbate) 
[37]. 
Administration of BSO to adult mice or rats does not 
appreciably decrease glutathione levels of the brain be- 
cause BSO is not effectively transported across the blood- 
brain barrier. In contrast, treatment of newborn rats with 
BSO leads to rapid decline of the glutathione l vel of the 
cerebral cortex and to striking electron microscopic find- 
ings (Fig. 8) [38]. Sections of cerebral cortex from BSO- 
treated newborn rats showed decreased numbers of mito- 
chondria, and those present were greatly enlarged. The 
findings obtained after giving BSO plus glutathione were 
similar; however, after giving BSO plus glutathione ster 
the cerebral mitochondria were indistinguishable from con- 
trols. 
Administration of BSO to newborn rats thus produces 
cataracts and cerebral damage, both effects associated with 
mitochondrial degeneration. In contrast o the results ob- 
tained when BSO is given to adult mice and rats, newborn 
rats and adult guinea pigs develop multiorgan failure (focal 
necrosis in liver, proximal tubular damage in kidney, very 
severe degeneration f mitochondria and lamellar bodies in 
lung) and die within a few days. A summary of these 
effects is given in Table 2. All of these effects (including 
early mortality) are prevented by giving glutathione sters 
or ascorbate. Of the several organs that we have studied, 
the heart and the stomach appear to be most resistant to the 
Table 2 
Effects of glutathione 
mice a 
deficiency in newborn rats, guinea pigs, and adult 
Effect Newborn rats Guinea pigs Adult mice 
Death (4-6 days) yes yes no 
Liver damage b yes yes no 
Kidney damage b yes yes no 
Lung damage b yes c yes yes c 
Brain damage b yes no no 
Lens, cataracts b yes no no 
a These effects are largely prevented by administration of glutathione 
esters or of ascorbate. 
b Associated with mitochondrial degeneration (swelling, loss of cristae, 
etc.). 
c More severe in newborn rats than in adult mice. 
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Fig. 9. Glutathione-ascorbic acid interrelationships (from [6]). 
effects of glutathione deficiency; thus, electron microscopy 
of these organs has not revealed evidence of mitochondrial 
or other types of damage. Although mitochondria re 
generally regarded to be deficient in catalase, this enzyme 
has been detected in rat heart mitochondria [39], and this 
may explain the resistance of heart o damage that we have 
observed [15]. 
The discovery that the lethal and other effects of glu- 
tathione deficiency can be prevented by giving ascorbate 
(dose, about 1 mmol/kg of body weight) was made in the 
course of studies on newborn rats [37]; later work on 
guinea pigs, which - like newborn rats - do not synthesize 
ascorbate, and on adult mice, which do, has shown that 
there are significant interrelationships between glutathione 
and ascorbate in animals (for reviews, see [6,40]). 
Death and tissue damage produced in newborn rats by 
glutathione deficiency are accompanied by a marked de- 
crease of tissue levels of ascorbate; for example, after 
giving BSO to newborn rats for 3,5 days there was about 
an 80% decrease of ascorbate in the liver; similar results 
were obtained for other tissues, and there was a significant 
increase in the dehydroascorbate levels. The tissue ascor- 
bate levels of glutathione-deficient a imals were increased 
by giving ascorbate (as expected), but interestingly, giving 
ascorbate also led to higher glutathione levels. Thus, the 
mitochondrial glutathione levels were 2.7- to 6.0-fold 
higher in the tissues of newborn rats given BSO plus 
ascorbate as compared to those given only BSO. It is 
evident hat ascorbate spares glutathione under these con- 
ditions. Sparing of glutathione by ascorbate was also ob- 
served in studies on adult mice, but the findings differ 
because adult mice can synthesize ascorbate. As noted 
(Table 2), treatment of adult mice does not lead to early 
mortality because the tissues are protected by the presence 
of significant amounts of ascorbate. In fact, treatment of 
adult mice with BSO actually leads to increased ascorbate 
synthesis [41]. The mechanism by which glutathione defi- 
ciency stimulates ascorbate synthesis i  not yet known, but 
may be expected to be of interest. 
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Table 3 
Experimental models of GSH deficiency and ascorbate deficiency 
Model Species (Ref.) Treatment Result 
I. adult mouse [5,47] BSO tissue damage 
BSO + GSH-ester protection 
BSO + Ascorbate protection 
2. newborn rat [36,37] BSO tissue damage; death, approx. 5days 
BSO + GSH-ester protection 
BSO + ascorbate protection 
3. guinea pig [48] BSO tissue damage; death, approx. 5days 
BSO + ascorbate protection 
4. guinea pig [42] )  ascorbate-deficient diet scurvy; death, approx. 21 days 
ascorbate-deficient diet + GSH-ester scurvy prevented for at least 40 days 
ascorbate-deficient diet + GSH a death, approx. 9days 
Guinea pigs given an ascorbate-deficient die and GSH itself (3.75 mmol/kg per day) showed hair loss, loss of weight, and became moribund after 
approx. 9 days. Identical treatment ofcontrol animals did not cause toxicity, but similar toxicity was found with higher doses of GSH (7.5 mmol/kg per 
day). (No toxicity was found with comparable doses of GSH ester.) From [6]. 
There is now good evidence that ascorbate can spare 
glutathione, but it is of interest hat the converse is also 
true, i.e., that glutathione can spare ascorbate. Thus, it is 
well known that guinea pigs given an ascorbate-deficient 
diet develop scurvy and die within 21-24 days. Treatment 
of such animals with glutathione ster was found to signifi- 
cantly delay the onset of scurvy; there were no signs of 
scurvy after 40 days [42]. Thus, when guinea pigs receiv- 
ing a scorbutic diet were given glutathione ster the tissue 
ascorbate levels, as well as the glutathione levels, were 
higher than those of saline-treated controls. The loss of 
ascorbate was slowed in the presence of higher levels of 
glutathione. An attempt o explain the findings in terms of 
known reactions is given in Fig. 9. Both ascorbate and 
glutathione can react with hydrogen peroxide and oxygen 
free radicals (designated [O] in Fig. 9). Several proteins 
have been found that catalyze glutathione-dependent dehy- 
droascorbate r duction including glutaredoxin and protein 
disulfide isomerase [43]. The reaction also takes place 
rapidly nonenzymatically and may be driven by glu- 
tathione disulfide reductase [6]. 
There is significant redundancy in the functions of 
glutathione and ascorbate, which suggests that this antioxi- 
dant function is of major importance to cells. Nevertheless, 
ascorbate and glutathione ach have some separate func- 
tions; there are probably critically essential minimum lev- 
els of these cellular components. Several animal models 
that have been used for study of glutathione and ascorbate 
deficiency are summarized in Table 3. It is notable that 
doses of ascorbate of 1 mmol per kg of body weight are 
sufficient to provide protection. Much higher doses of 
ascorbate are toxic. High doses of glutathione are also 
toxic to newborn mice and to guinea pigs (especially to 
ascorbate-deficient guinea pigs; see Table 3). Additional 
consideration of this subject has been given elsewhere [6]. 
The metabolism of glutathione in mitochondria ppears 
to be largely concerned with transport of glutathione into 
the organelle, oxidation to glutathione disulfide, and reduc- 
tion of the latter to glutathione. The major enzymes in- 
volved are thus, glutathione peroxidase and glutathione 
disulfide reductase. Presently available data suggest hat 
glutaredoxin and protein disulfide isomerase activities are 
not present [44]; glutathione S-transferases seem not to be 
of major quantitative importance, but see [45,46], and the 
enzymes of the y-glutamyl cycle are apparently lacking 
(Table 1). Glutathione is of major importance in protecting 
mitochondria from oxidative damage, and ascorbate is very 
probably also involved in this protective function. 
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